Nasiruddin Nazarally
Internal Medicine · North Miami, FLNPI 1174560569
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 196 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,288 and has fallen 94.0% since, to $77 in 2025.
Across 196 payments — averaging $21.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$604
- AstraZeneca$522
- Sanofi-aventis U.S. LLC$517
- Boehringer Ingelheim$415
- Lilly USA, LLC$408
- Novo Nordisk$327
- plus $1K from 23 others
What the payments were for
- Food & beverage$4,05297%
- Education$50%
- Gifts$1193%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 27 | $604 |
| AstraZeneca | 29 | $522 |
| Sanofi-aventis U.S. LLC | 20 | $517 |
| Boehringer Ingelheim | 16 | $415 |
| Lilly USA, LLC | 17 | $408 |
| Novo Nordisk | 20 | $327 |
| Gilead | 11 | $321 |
| Pfizer | 10 | $168 |
| Mannkind Corporation | 3 | $128 |
| Astellas Pharma US Inc | 6 | $96 |
| GSK | 5 | $96 |
| AbbVie(2 entities) | 5 | $90 |
| Shield Therapeutics Inc | 3 | $49 |
| Kowa Pharmaceuticals America, Inc. | 3 | $47 |
| Viiv Healthcare Company | 2 | $47 |
| Theratechnologies Inc. | 1 | $44 |
| Amarin Pharma, Inc. | 3 | $42 |
| Almatica Pharma LLC | 3 | $41 |
| Novartis | 2 | $37 |
| Globus Medical | 1 | $31 |
| Redhill Biopharma Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Global Blood Therapeutics, Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $17 |
| Exact Sciences | 1 | $17 |
| Bayer | 1 | $16 |
| Amgen | 1 | $16 |
| Alvogen Inc | 1 | $15 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$124
- Vemlidy$121
- FARXIGA$112
- SOLIQUA 100/33$101
How this compares
$4,176 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 39 | $325 |
| Atorvastatin Calcium | 48 | $292 |
| Losartan Potassium | 29 | $289 |
| Amlodipine Besylate | 34 | $152 |
| Metformin Hcl | 28 | $134 |
| Tamsulosin Hcl | 21 | $134 |
| Lisinopril | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in North Miami
- Manuel Suarez BarceloNorth Miami$175K
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.